EBMT 2016

3:06
Defibrotide: Redefining the treatment for severe veno-occlusive disease (sVOD)
Paul Richardson
3:01
Mohamad Mohty on EBMT 2016
Mohamad Mohty
1:09
Blinatumomab for treating ALL
Giovanni Martinelli
2:14
Monoclonal antibodies for difficult-to-treat multiple myeloma
Mohamad Mohty
4:12
Transforming healthcare with Twitter: A physician’s perspective
Navneet Majhail
3:12
Graft-versus-host disease (GvHD): Advances at EBMT 2016
Mohamad Mohty
1:58
New monoclonal antibodies for ALL treatment
Arnon Nagler
3:28
Engaging healthcare professionals and patients with social media
Michael Thompson
1:53
Change of landscape in CLL treatment
John Gribben
1:48
Strategies to reduce graft-versus-host disease (GvHD)
Miguel Perales
4:24
Key questions in the field of CD19 CAR T-cell therapy
Catherine Bollard
1:46
Separation of graft-versus-leukemia from graft-versus-host disease (GvHD)
Arnon Nagler
1:47
Improving the assessment of response in relapsed MM
Bruno Paiva
1:08
Big topics for nurses at EBMT 2016
Arno Mank
1:38
The not-invented-here syndrome in nursing research
Arno Mank
2:28
The changing role of nurses in bone marrow biopsies
John Murray
VJHemOnc VJHemOnc is intended for Healthcare Professionals only

By choosing to continue, you are confirming that you are a healthcare professional

The content of VJHemOnc is intended for healthcare professionals